A detailed history of Rothschild Investment LLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 80 shares of RCUS stock, worth $1,420. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 30 166.67%
Holding current value
$1,420
Previous $457,000 167.61%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$13.69 - $18.01 $684 - $900
50 Added 166.67%
80 $1.22 Million
Q2 2024

Jul 30, 2024

BUY
$14.59 - $18.48 $437 - $554
30 New
30 $457,000
Q1 2024

Jul 31, 2024

SELL
$14.83 - $20.18 $296 - $403
-20 Reduced 66.67%
10 $189,000

Others Institutions Holding RCUS

About Arcus Biosciences, Inc.


  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.28B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.